| Line item | 2025-03-31 FY | 2024-03-31 FY | 2023-03-31 FY | 2022-03-31 FY | 2021-03-31 FY |
|---|---|---|---|---|---|
| Revenue | – | – | – | – | – |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | – | – | – | – | – |
| R&D | $3.13M | $12.54M | $8.21M | $6.77M | $7.31M |
| SG&A | $4.25M | $5.66M | $8.36M | $8.82M | $5.13M |
| Operating Income | -$7.38M | -$18.20M | -$16.57M | -$15.59M | -$12.44M |
| Interest Expense | $3.00K | $32.00K | $9.00K | $43.00K | $177.00K |
| Tax Expense | -$3.00K | -$10.55M | -$17.86M | $4.35M | $2.30M |
| Net Income | -$6.78M | -$75.38M | -$104.67M | -$19.17M | -$17.19M |
| EPS (basic) | -5.7200 | -3.8900 | – | – | – |
| EPS (diluted) | -5.7200 | -3.8900 | – | – | – |
| Shares (diluted) | $1.18M | $19.34M | $2.43M | – | – |